Publications by authors named "Swarnendu Chatterjee"

Claim this Profile
A
A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting β-agonist reliever or ICS/formoterol reliever only in mild asthma.
Arzu Yorgancıoğlu, Alvaro A Cruz, Gabriel Garcia, Kim L Lavoie, Nicolas Roche, Swarnendu Chatterjee

Respir Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting β-agonist reliever, as-needed ICS/formoterol, or ICS/formoterol maintenance and reliever therapy.
Nicolas Roche, Arzu Yorgancıoğlu, Alvaro A Cruz, Gabriel Garcia, Kim L Lavoie, Swarnendu Chatterjee

Respir Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A network meta-analysis of the association between patient traits and response to regular dosing with ICS/long-acting β-agonist plus short-acting β agonist reliever or maintenance and reliever therapy for asthma.
Arzu Yorgancıoğlu, Alvaro A Cruz, Gabriel Garcia, Kim L Lavoie, Nicolas Roche, Swarnendu Chatterjee

Respir Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis.
Shelby Sydnor, Swarnendu Chatterjee, Philip Cooney, Simarjeet Kaur, Tom Macmillan

Diabetes Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis